Related Experiment Video
Updated: Jul 13, 2025

Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay
Published on: April 5, 2019
A Rare Case Report of Neurological Condition: Moersch-Woltman Syndrome with Positive Anti-GAD Antibodies
1MBBS, Extern, Neurology Services Inc, Alexandria, Virginia, USA.
Background:
Moersch-Woltman Syndrome (MWS), also known as Stiff person syndrome (SPS), is a rare, progressive condition of the central nervous system. Symptoms can include severe immobility, rigidity, and painful muscle spasms in the trunk and limbs. Muscle spasms can occur in MWS patients because they are more sensitive to noise, rapid movements, and mental disturbance. The condition affects women twice as frequently as it does males. It is a rare disease, affecting only 1-2 people per million. The case report aims to highlight the importance of the diagnostic challenges associated with MWS and the significance of glutamic acid decarboxylase (GAD) antibodies.
The Case:
A 57-year-old female patient presents with history of migraine headaches, anxiety, and depression. The patient experienced widespread and distressing muscle spasms affecting the shoulders, upper and lower back, and limited range of motion in the neck. Physical examination revealed dense diffuse muscle stiffness throughout the body. Further investigations were ordered, including a comprehensive range of laboratory tests and imaging tests. A positive test for GAD antibodies confirmed the diagnosis of MWS. Treatment included administration of Clonazepam and Baclofen. A follow-up appointment, three weeks later, indicated a noticeable 15-20% reduction in spasticity.
Conclusion:
This case highlights the crucial role of anti-GAD antibodies in confirming the diagnosis of SPS. Healthcare professionals should consider testing for these antibodies in patients presenting with the described symptoms. A multidisciplinary approach involving neurologists, physical therapists, psychiatrists, and orthopedic surgeons is essential to provide comprehensive care and optimizing outcomes for individuals with MWS.
Insights
Moersch-Woltman Syndrome (MWS), or Stiff Person Syndrome (SPS), is a rare neurological disorder. Diagnosing MWS is challenging, but testing for glutamic acid decarboxylase (GAD) antibodies is crucial for confirmation.
Area of Science:
- Neurology
- Immunology
Background:
- Moersch-Woltman Syndrome (MWS), also known as Stiff Person Syndrome (SPS), is a rare, progressive central nervous system disorder.
- Characterized by immobility, rigidity, and painful muscle spasms, MWS affects women twice as frequently as men.
- Prevalence is low, impacting 1-2 individuals per million, with symptoms exacerbated by external stimuli.
Purpose of the Study:
- To highlight diagnostic challenges in Moersch-Woltman Syndrome (MWS).
- To emphasize the significance of glutamic acid decarboxylase (GAD) antibodies in MWS diagnosis.
- To present a case report illustrating MWS diagnosis and management.
Main Methods:
- Case report of a 57-year-old female patient with symptoms of muscle spasms and stiffness.
- Diagnostic workup included laboratory tests and imaging.
- Confirmation of MWS through positive GAD antibody testing.
Main Results:
- The patient presented with widespread muscle spasms and severe stiffness.
- Diagnosis of MWS was confirmed by the presence of GAD antibodies.
- Treatment with Clonazepam and Baclofen resulted in a 15-20% reduction in spasticity within three weeks.
Conclusions:
- Anti-GAD antibodies are critical for confirming Stiff Person Syndrome (SPS) diagnosis.
- Healthcare providers should consider GAD antibody testing for patients with suggestive symptoms.
- A multidisciplinary approach is essential for comprehensive MWS patient care.
More Related Videos
10:19High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
05:55Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
Published on: December 1, 2023
Related Concept Videos
Generalized Anxiety Disorder
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...